Clinical Observation on the Combination of Ear Tip Bleeding and Babao Eye Ointment Ion Introduction in the Treatment of Needle Eye Heat Toxin Obstruction Syndrome

Abstract

This study aimed to observe the clinical effects of ear tip exofusion combined withMayinglong Babao eye ointment in the treatment of needle eye conditions. From April 2022 to April 2023, a total of 120 patients (aged 6-25 years) with 120 affected eyes were diagnosed and treated at Ankang Eye Hospital. Using a random allocation method involving sequentially coding, opaque, and sealed envelopes, the patients were divided into an observation group and a control group, with 60 cases in each group. The control group received standard bleeding treatment, while the observation group underwent additional ear tip exofusion. Clinical efficacy, cure time, adverse reactions, and recurrence rates were compared between the two groups.Results showed that the total response rate in the observation group (91.67%) was significantly higher than that in the control group (83.33%) at the same time point (P < 0.05). Additionally, the cure time in the observation group was shorter than that in the control group, with a statistically significant difference (P < 0.05). No adverse events were reported in either group, and there was no statistically significant difference in the recurrence rate between the two groups (all P > 0.05). The combination of ear tip exofusion and Mayinglong Babao eye ointment demonstrated remarkable efficacy in treating needle eye conditions, suggesting its potential as a preferred external treatment option for such conditions, particularly in primary healthcare settings.